The FreeStyle Libre 2 sensor is worn on the back of the upper arm for up to 14 days and measures glucose every minute to help users and their healthcare providers make informed treatment decisions.

Recent studies showed that users of the FreeStyle Libre system have improved glucose control, 5 decreased time in hyperglycemia 6 and hypoglycemia 7 as well as reduced hospitalizations 8 and HbA1c ...

Abbott's FreeStyle Libre 2 system represents a significant advancement in diabetes management. The system continues to be the market leader in Alberta and is Canada's leading sensor-based glucose ...

Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, is now available to Canadians living with diabetes ...

Notably, Abbott’s Freestyle Libre line is years ahead in Europe of where it is in the US, due to the difficulties of FDA clearance. Since Freestyle Libre 1 only came to the US last fall and still ...

Data from Abbott’s REFLECT study show for the first time that the use of its continuous glucose monitoring technology, Freestyle Libre, can help lessen the severity of cardiovascular complications in ...

TORONTO — The Ontario government is now providing coverage for the FreeStyle Libre 2 system, the latest flash glucose monitoring system to become available, under the province’s publicly-funded drug ...

The affected FreeStyle Libre 3 sensors were distributed during the first half of May this year. To check if yours is included, look for the serial number on the package, app or reader, and then ...

The FreeStyle Libre 3 glucose monitoring system (Abbott) has been granted a CE mark for use by people with diabetes in the countries of the European Union (EU). The next-generation FreeStyle Libre ...